Article
FDA settles drug compounding suit, agrees to speed its review of bulk ingredients
Rating:
0.0
Views:
87
Likes:
1
Library:
1
Back in 2014, the FDA made very clear to the growing but under-regulated pharma compounding world that it would begin implementing a new law from Congress requiring the agency to develop a list of bulk drug substances (or active ingredients) that companies may use to compound drugs. But the nomination
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value